Pzena Investment Management LLC Lowers Stock Position in TriMas Corporation $TRS

Pzena Investment Management LLC cut its holdings in shares of TriMas Corporation (NASDAQ:TRSFree Report) by 40.2% during the third quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,302,265 shares of the industrial products company’s stock after selling 875,496 shares during the period. Pzena Investment Management LLC owned 3.20% of TriMas worth $50,320,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in TriMas by 4.4% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,120 shares of the industrial products company’s stock worth $565,000 after buying an additional 1,014 shares during the period. Jane Street Group LLC bought a new position in shares of TriMas in the 1st quarter worth $868,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of TriMas during the 2nd quarter worth $1,026,000. Ethic Inc. boosted its position in TriMas by 28.5% during the second quarter. Ethic Inc. now owns 13,598 shares of the industrial products company’s stock valued at $386,000 after purchasing an additional 3,015 shares in the last quarter. Finally, AlphaQuest LLC grew its stake in TriMas by 41,400.0% in the second quarter. AlphaQuest LLC now owns 16,185 shares of the industrial products company’s stock valued at $463,000 after purchasing an additional 16,146 shares during the last quarter. Institutional investors own 99.42% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have commented on TRS shares. Weiss Ratings reissued a “hold (c+)” rating on shares of TriMas in a research report on Monday, December 29th. Wall Street Zen lowered shares of TriMas from a “buy” rating to a “hold” rating in a research note on Saturday, December 6th. BWS Financial restated a “buy” rating and issued a $45.00 target price on shares of TriMas in a research note on Friday, December 5th. KeyCorp cut their price target on shares of TriMas from $45.00 to $38.00 and set an “overweight” rating on the stock in a report on Thursday, November 13th. Finally, Zacks Research lowered TriMas from a “strong-buy” rating to a “hold” rating in a report on Thursday, December 11th. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat, TriMas currently has an average rating of “Moderate Buy” and a consensus price target of $41.50.

Get Our Latest Stock Analysis on TriMas

TriMas Trading Up 1.2%

Shares of TriMas stock opened at $37.03 on Thursday. The firm’s 50 day simple moving average is $35.18 and its two-hundred day simple moving average is $35.90. The firm has a market capitalization of $1.51 billion, a price-to-earnings ratio of 34.29 and a beta of 0.57. TriMas Corporation has a 12-month low of $19.33 and a 12-month high of $40.34. The company has a current ratio of 2.68, a quick ratio of 1.42 and a debt-to-equity ratio of 0.56.

TriMas Company Profile

(Free Report)

TriMas Corporation is a diversified industrial company headquartered in Bloomfield Hills, Michigan. Established in 1980, TriMas has built a global reputation for designing and manufacturing specialized products that serve a wide array of end markets. The company operates through multiple segments, each focused on high-demand niches where engineered solutions and rigorous quality standards are essential.

The Packaging segment supplies closures, dispensing systems and related components for the personal care, household chemicals, food and beverage, and pharmaceutical markets.

Further Reading

Want to see what other hedge funds are holding TRS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for TriMas Corporation (NASDAQ:TRSFree Report).

Institutional Ownership by Quarter for TriMas (NASDAQ:TRS)

Receive News & Ratings for TriMas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriMas and related companies with MarketBeat.com's FREE daily email newsletter.